Betta Pharmaceuticals Co., Ltd., backed by Sequoia Capital China and other investors, has completed an initial public offering on the Shenzhen Stock Exchange’s NASDAQ-style ChiNext Board, raising RMB720 million (US$106 million).
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription?